苏州信诺维医药科技股份有限公司
Total raised: $145M
Investors 1
| Date | Name | Website |
| - | Loyal Vall... | loyalvalle... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.08.2020 | Series C | $145M | - |
Mentions in press and media 2
| Date | Title | Description |
| 17.09.2021 | Everest Medicines, Sinovent and SinoMab Announce Licensing Agreement for Global Development, Manufacturing and Commercialization of Novel BTK Inhibitor in Renal Diseases | SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest") announced today that it has entered into an exclusive licensing agreement with Suzhou Sinovent Pharmaceuticals Co., Ltd. ("Sinovent") a... |
| 25.08.2020 | Chinese biopharma startup Sinovent closes $145m Series C round | Premium Chinese biopharmaceutical startup Sinovent has raised 1 billion yuan ($145 million) in a Series C round of financing co-led by Loyal Valley Innovation Capital. Continue reading this story with a subscription to DealStreetAsia. Subsc... |